These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 26497450)

  • 1. The association of molecular typing, vancomycin MIC, and clinical outcome for patients with methicillin-resistant Staphylococcus aureus infections.
    Chen CP; Liu MF; Lin CF; Lin SP; Shi ZY
    J Microbiol Immunol Infect; 2017 Oct; 50(5):619-626. PubMed ID: 26497450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An investigation of vancomycin minimum inhibitory concentration creep among methicillin-resistant Staphylococcus aureus strains isolated from pediatric patients and healthy children in Northern Taiwan.
    Chang CN; Lo WT; Chan MC; Yu CM; Wang CC
    J Microbiol Immunol Infect; 2017 Jun; 50(3):362-369. PubMed ID: 26297168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trend in vancomycin susceptibility and correlation with molecular characteristics of methicillin-resistant Staphylococcus aureus causing invasive infections in Taiwan: results from the Tigecycline in vitro Surveillance in Taiwan (TIST) study, 2006-2010.
    Tsao SM; Wang WY; Ko WC; Huang CH; Lu CT; Chuang YC; Liu CY; Liao CH; Chen YS; Liu YC; Chen WY; Jang TN; Lin HC; Chen CM; Shi ZY; Pan SC; Yang JL; Kung HC; Liu CE; Cheng YJ; Liu JW; Sun W; Wang LS; Yu KW; Chiang PC; Lee MH; Lee CM; Hsu GJ; Chen YH; Lu PL; Thomas CY; Hsueh PR
    Diagn Microbiol Infect Dis; 2014 Oct; 80(2):162-7. PubMed ID: 25053202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular epidemiology and phenotypes of invasive methicillin-resistant vancomycin-intermediate Staphylococcus aureus in Taiwan.
    Wang WY; Chiu CF; Lee YT; Hsueh PR; Tsao SM
    J Microbiol Immunol Infect; 2022 Dec; 55(6 Pt 2):1203-1210. PubMed ID: 34635425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of vancomycin MIC creep on patients with methicillin-resistant Staphylococcus aureus bacteremia.
    Yeh YC; Yeh KM; Lin TY; Chiu SK; Yang YS; Wang YC; Lin JC
    J Microbiol Immunol Infect; 2012 Jun; 45(3):214-20. PubMed ID: 22571999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro activity of linezolid, tigecycline, and daptomycin on methicillin-resistant Staphylococcus aureus blood isolates from adult patients, 2006-2008: stratified analysis by vancomycin MIC.
    Kao TM; Wang JT; Weng CM; Chen YC; Chang SC
    J Microbiol Immunol Infect; 2011 Oct; 44(5):346-51. PubMed ID: 21524980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of vancomycin-intermediate Staphylococcus aureus (VISA) and heterogeneous VISA among methicillin-resistant S. aureus with high vancomycin minimal inhibitory concentrations in Taiwan: A multicenter surveillance study, 2012-2013.
    Huang SH; Chen YC; Chuang YC; Chiu SK; Fung CP; Lu PL; Wang LS; Wu TL; Wang JT
    J Microbiol Immunol Infect; 2016 Oct; 49(5):701-707. PubMed ID: 26320398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular typing and phenotype characterization of methicillin-resistant Staphylococcus aureus isolates from blood in Taiwan.
    Wang WY; Chiueh TS; Sun JR; Tsao SM; Lu JJ
    PLoS One; 2012; 7(1):e30394. PubMed ID: 22291948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methicillin-resistant Staphylococcus aureus (MRSA) staphylococcal cassette chromosome mec genotype effects outcomes of patients with healthcare-associated MRSA bacteremia independently of vancomycin minimum inhibitory concentration.
    Chen SY; Liao CH; Wang JL; Chiang WC; Lai MS; Chie WC; Chen WJ; Chang SC; Hsueh PR
    Clin Infect Dis; 2012 Nov; 55(10):1329-37. PubMed ID: 22911641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determining vancomycin Etest MICs in patients with MRSA bloodstream infection does not support switching antimicrobials.
    Hos NJ; Jazmati N; Stefanik D; Hellmich M; AlSael H; Kern WV; Rieg S; Wisplinghoff H; Seifert H; Kaasch AJ
    J Infect; 2017 Mar; 74(3):248-259. PubMed ID: 28017826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. More accurate measurement of vancomycin minimum inhibitory concentration indicates poor outcomes in meticillin-resistant Staphylococcus aureus bacteraemia.
    Shoji H; Maeda M; Shirakura T; Takuma T; Ugajin K; Fukuchi K; Ishino K; Niki Y
    Int J Antimicrob Agents; 2015 Nov; 46(5):532-7. PubMed ID: 26364848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vancomycin MIC creep in methicillin-resistant Staphylococcus aureus (MRSA) isolates from 2006 to 2010 in a hospital in China.
    Chang W; Ma X; Gao P; Lv X; Lu H; Chen F
    Indian J Med Microbiol; 2015; 33(2):262-6. PubMed ID: 25865979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology and susceptibilities of methicillin-resistant Staphylococcus aureus in Taiwan: emphasis on chlorhexidine susceptibility.
    Sheng WH; Wang JT; Lauderdale TL; Weng CM; Chen D; Chang SC
    Diagn Microbiol Infect Dis; 2009 Mar; 63(3):309-13. PubMed ID: 19216941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methicillin-resistant Staphylococcus aureus bacteremia in hemodialysis and nondialysis patients.
    Kan LP; Lin JC; Chiu SK; Yeh YC; Lin TY; Yang YS; Wang YC; Wang NC; Yeh KM; Chang FY
    J Microbiol Immunol Infect; 2014 Feb; 47(1):15-22. PubMed ID: 23040238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nosocomial methicillin-resistant Staphylococcus aureus (MRSA) bacteremia in Taiwan: mortality analyses and the impact of vancomycin, MIC = 2 mg/L, by the broth microdilution method.
    Wang JL; Wang JT; Sheng WH; Chen YC; Chang SC
    BMC Infect Dis; 2010 Jun; 10():159. PubMed ID: 20529302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is there a clinical association of vancomycin MIC creep, agr group II locus, and treatment failure in MRSA bacteremia?
    de Sanctis JT; Swami A; Sawarynski K; Gerasymchuk L; Powell K; Robinson-Dunn B; Carpenter CF; Sims MD
    Diagn Mol Pathol; 2011 Sep; 20(3):184-8. PubMed ID: 21817905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Community-associated MRSA strain ST72-SCCmecIV causing bloodstream infections: clinical outcomes and bacterial virulence factors.
    Park KH; Chong YP; Kim SH; Lee SO; Choi SH; Lee MS; Jeong JY; Woo JH; Kim YS
    J Antimicrob Chemother; 2015 Apr; 70(4):1185-92. PubMed ID: 25433004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship of vancomycin minimum inhibitory concentration to mortality in patients with methicillin-resistant Staphylococcus aureus hospital-acquired, ventilator-associated, or health-care-associated pneumonia.
    Haque NZ; Zuniga LC; Peyrani P; Reyes K; Lamerato L; Moore CL; Patel S; Allen M; Peterson E; Wiemken T; Cano E; Mangino JE; Kett DH; Ramirez JA; Zervos MJ;
    Chest; 2010 Dec; 138(6):1356-62. PubMed ID: 20558550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vancomycin MIC susceptibility testing of methicillin-susceptible and methicillin-resistant Staphylococcus aureus isolates: a comparison between Etest® and an automated testing method.
    Bland CM; Porr WH; Davis KA; Mansell KB
    South Med J; 2010 Nov; 103(11):1124-8. PubMed ID: 20890258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between the MIC of vancomycin and clinical outcome in patients with MRSA nosocomial pneumonia.
    Choi EY; Huh JW; Lim CM; Koh Y; Kim SH; Choi SH; Kim YS; Kim MN; Hong SB
    Intensive Care Med; 2011 Apr; 37(4):639-47. PubMed ID: 21253703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.